CASE.EDU:    HOME | DIRECTORIES | SEARCH
 
case western reserve university

Cardiovascular Research Institute
 
 

 

Marco Costa, MD, PhD
Director, Heart Vascular Institute University Hospitals Case Medical Center
Phone: 216-368-4737
Fax: 216-368-3959
E-mail: marco.costa@case.edu


Research Summary:

Cardiovascular Imaging

Original Publications: (last 5 years)

    • Costa MA, Sabate M, Angiolillo DJ, Jimenez-Quevedo P, Teirstein P, Carter A, Leon MB, Moses J, Zenni M, Yakubov S, Guzman LA, Gilmore P, Macaya C, Bass TA. Intravascular Ultrasound Characterization of the Black Hole Phenomenon after Drug-eluting Stent Implantation. Am J Cardiol 2006; 97:203-6.
    • Cervinka P, Costa MA, Angiolillo DJ, Spacek R, Bystron M, Kvasnak M, Veselka J, Nanda H, Futamatsu H, Futamatsu K. Head-to-head comparison between sirolimus-eluting and paclitaxel-eluting stents in patients with complex coronary artery disease: An intravascular ultrasound study. Catheter Cardiovasc Interv. 2006; 67:846-51.
    • Jiménez-Quevedo P, Sabaté M, Angiolillo DJ, Costa MA, Alfonso F, Gómez-Hospital JA, Hernández-Antolín R, Bañuelos C, Goicolea J, Fernández-Avilés F, Bass TA, Escaned J, Moreno R, Fernández C, Macaya C. Three-dimensional intravascular ultrasound evaluation of the vascular effects of sirolimus-eluting versus bare metal stents in diabetic patients: Insights from the DIABETES trial. J Am Coll Cardiol 2006; 47:2172-9.
    • Futamatsu H, Sabaté M, Angiolillo DJ, Jimenez-Quevedo P, Corros C, Morikawa-Futamatsu K, Alfonso F, Jiang J, Cervinka P, Hernandez-Antolin R, Macaya C, Bass TA, Costa MA. Characterization of Plaque Prolapse after Drug-eluting Stent Implantation in Diabetic Patients: A Three-dimensional Volumetric Intravascular Ultrasound Outcome Study. J Am Coll Cardiol 2006; 48:1139-45.
    • Angiolillo DJ., Fernández-Ortiz A., Bernardo E., Ramirez C., Sabaté M., Jimenez-Quevedo P, Hernández R., Moreno R., Escaned J., Alfonso F., Bañuelos C., Costa MA, Bass TA, Macaya C. Influence of Aspirin Resistance on Platelet Function Profiles in Patients on Long-term Aspirin and Clopidogrel After Pecutaneous Coronary Intervention. Am J Cardiol 2006; 97:38-43.
    • Angiolillo D.J., Fernández-Ortiz A., Bernardo E., Ramirez C., Sabaté M., Jimenez-Quevedo P, Hernández R., Moreno R., Escaned J., Alfonso F., Bañuelos C., Costa MA, Bass TA, Macaya C. Clopidogrel withdrawal is associated with pro-inflammatory and pro-thrombotic effects in diabetic patients with coronary artery disease. Diabetes 2006;55:780-4.
    • Angiolillo DJ. Futamatsu K, Costa MA, Bass, TA. How to develop antiplatelet treatment for drug eluting stent? International Review of Thrombosis 2006; 1: 48-57.
    • Angiolillo D.J., Bernardo E., Ramirez C., Costa MA, Sabaté M., Jimenez-Quevedo P, Hernández R., Moreno R., Escaned J., Alfonso F., Bañuelos C., Bass TA, Macaya C Fernández-Ortiz A. Insulin Therapy is Associated with Platelet Dysfunction in Patients with Type 2 Diabetes Mellitus on Dual Oral Antiplatelet Treatment. J Am Coll Cardiol 2006; 48:298-304.
    • Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramirez C, Cavallari U, Trabetti E, Sabate M, Hernandez R, Moreno R, Escaned J, Alfonso F, Banuelos C, Costa MA, Bass TA, Pignatti PF, Macaya C. Contribution of Gene Sequence Variations of the Hepatic Cytochrome P450 3A4 Enzyme to Variability in Individual Responsiveness to Clopidogrel. Arterioscler Thromb Vasc Biol. 2006; 26:1895-900.
    • Bernardo E, Angiolillo DJ, Ramirez C, Cavallari U, Trabetti E, Sabate M, Hernandez R, Moreno R, Escaned J, Alfonso F, Banuelos C, Costa MA, Bass TA, Pignatti PF, Macaya C, Fernandez-Ortiz A. Influence of the CD14 C(-260)T Promoter Polymorphism on C-Reactive Protein Levels in Patients with Coronary Artery Disease. Am J Cardiol 2006; 98:1182-4.